|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
283 a.a.
|
 |
|
|
|
|
|
|
|
270 a.a.
|
 |
|
|
|
|
|
|
|
236 a.a.
|
 |
|
|
|
|
|
|
|
40 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Virus
|
 |
|
Title:
|
 |
Crystal structure of a human rhinovirus type 14:human immunodeficiency virus type 1 v3 loop chimeric virus mn-iii-2
|
|
Structure:
|
 |
Coat protein vp1 (p1d). Chain: a. Engineered: yes. Chimera of hrv14 coat protein vp2 (p1b) and the v3 loop of HIV-1 gp120. Chain: b. Engineered: yes. Other_details: the chimera consists of the hrv14 coat protein vp2 (p1b) and residues 314-325 of HIV-1 gp120..
|
|
Source:
|
 |
Human rhinovirus 14. Organism_taxid: 12131. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: h1-hela cells. Human rhinovirus 14, human immunodeficiency virus type 1 group m subtype b (isolate mn). HIV-1. Organism_taxid: 12131, 11696.
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
J.Ding,A.D.Smith,S.C.Geisler,X.Ma,G.F.Arnold,E.Arnold
|
Key ref:
|
 |
J.Ding
et al.
(2002).
Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1.
Structure,
10,
999.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-Oct-01
|
Release date:
|
17-Jul-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P03303
(POLG_HRV14) -
Genome polyprotein from Human rhinovirus 14
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2179 a.a.
283 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P03303
(POLG_HRV14) -
Genome polyprotein from Human rhinovirus 14
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2179 a.a.
270 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P05877
(ENV_HV1MN) -
Envelope glycoprotein gp160 from Human immunodeficiency virus type 1 group M subtype B (isolate MN)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
856 a.a.
270 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B, C, D:
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, B, C, D:
E.C.3.4.22.28
- picornain 3C.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains A, B, C, D:
E.C.3.4.22.29
- picornain 2A.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains A, B, C, D:
E.C.3.6.1.15
- nucleoside-triphosphate phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
|
 |
 |
 |
 |
 |
ribonucleoside 5'-triphosphate
|
+
|
H2O
|
=
|
ribonucleoside 5'-diphosphate
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Structure
10:999
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1.
|
|
J.Ding,
A.D.Smith,
S.C.Geisler,
X.Ma,
G.F.Arnold,
E.Arnold.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We report the 2.7 A resolution structure of a chimeric rhinovirus, MN-III-2,
that displays part of the HIV-1 gp120 V3 loop and elicits HIV-neutralizing
antibodies. The V3 loop insert is dominated by two type I beta turns. The
structures of two adjacent tripeptides resemble those of analogous segments in
three Fab/V3 loop peptide complexes. Although two of the three corresponding
antibodies bind and neutralize MN-III-2 well, only one of the three can bind
without significant rearrangement. These results suggest that the V3 loop
insert: (1) can share some local conformational similarity to V3 loop sequences
presented on different structural frameworks; (2) must be able to adopt multiple
conformations, even in a relatively constrained environment; and (3) may mimic
the conformational variability of the epitope on HIV-1, increasing the
likelihood of eliciting appropriate neutralizing immune responses.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 5.
Figure 5. The Pocket Factor, Sphingosine (Shown as a Green
Ball-and-Stick Model), in the Binding Pocket of VP1 Located
below the External Canyon Region where Host Cell Receptor
Binding OccursVP1 and VP3 are shown in blue and red ribbons,
respectively. The side chains of the surrounding amino acid
residues that have close contacts with sphingosine are shown.
The interactions between sphingosine and the amino acid residues
are primarily hydrophobic in nature (=<3.6 Å, indicated with
dashed lines). Hydrogen bonds are indicated with solid lines.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2002,
10,
999-0)
copyright 2002.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Lapelosa,
G.F.Arnold,
E.Gallicchio,
E.Arnold,
and
R.M.Levy
(2010).
Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].
|
| |
J Mol Biol,
397,
752-766.
|
 |
|
|
|
|
 |
M.Lapelosa,
E.Gallicchio,
G.F.Arnold,
E.Arnold,
and
R.M.Levy
(2009).
In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes.
|
| |
J Mol Biol,
385,
675-691.
|
 |
|
|
|
|
 |
U.Katpally,
and
T.J.Smith
(2007).
Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus.
|
| |
J Virol,
81,
6307-6315.
|
 |
|
|
|
|
 |
A.M.Andrianov,
and
V.G.Veresov
(2006).
Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches.
|
| |
Biochemistry (Mosc),
71,
906-914.
|
 |
|
|
|
|
 |
F.Fabiola,
A.Korostelev,
and
M.S.Chapman
(2006).
Bias in cross-validated free R factors: mitigation of the effects of non-crystallographic symmetry.
|
| |
Acta Crystallogr D Biol Crystallogr,
62,
227-238.
|
 |
|
|
|
|
 |
T.Watabe,
H.Kishino,
Y.Okuhara,
and
Y.Kitazoe
(2006).
Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host.
|
| |
Genetics,
172,
1385-1396.
|
 |
|
|
|
|
 |
O.Hartley,
P.J.Klasse,
Q.J.Sattentau,
and
J.P.Moore
(2005).
V3: HIV's switch-hitter.
|
| |
AIDS Res Hum Retroviruses,
21,
171-189.
|
 |
|
|
|
|
 |
R.L.Stanfield,
M.K.Gorny,
C.Williams,
S.Zolla-Pazner,
and
I.A.Wilson
(2004).
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
|
| |
Structure,
12,
193-204.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Zhang,
A.A.Simpson,
R.M.Ledford,
C.M.Bator,
S.Chakravarty,
G.A.Skochko,
T.M.Demenczuk,
A.Watanyar,
D.C.Pevear,
and
M.G.Rossmann
(2004).
Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.
|
| |
J Virol,
78,
11061-11069.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.D.Bowman,
E.S.Chase,
A.W.Franz,
P.R.Chipman,
X.Zhang,
K.L.Perry,
T.S.Baker,
and
T.J.Smith
(2002).
An antibody to the putative aphid recognition site on cucumber mosaic virus recognizes pentons but not hexons.
|
| |
J Virol,
76,
12250-12258.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |